Kalexsyn, Inc.
Pharmaceutical ManufacturingMichigan, United States11-50 Employees
Dipharma, Inc. (formerly Kalexsyn) operates as a pharmaceutical development and manufacturing CRO, specializing in solving synthetic challenges across early-stage APIs, process impurities, custom synthesis, stable labeling, and medicinal chemistry. Its services are designed to provide clients with fixed-quote engagements and flexible short- to long-term FTE arrangements, supporting Phase 1 and early Phase 2 needs through cGMP kilolab facilities and accompanying QC capabilities. Based in Kalamazoo, Michigan, the company combines research laboratory work with process route development to deliver scalable solutions for complex chemical projects within the pharmaceutical sector. The organization targets pharmaceutical and biotech clients seeking specialized synthetic expertise and efficient project execution, addressing the need for robust early-stage development and impurity management. Dipharma expanded its footprint through corporate acquisition and operates within a broader European group, with recent international facility expansion noted in the news.
1-888-653-2347 
support@leadiq.com 
